This contribution summarizes the evidence from the natural history and pathology of this
disease that, given the high incidence of latent cancer, a policy of radical treatment at …

With the nearly simultaneous development of prostate-specific antigen (PSA), the automated
biopsy" gun," and a public interest in the early detection of prostate cancer, the number of …

The management of localized prostate cancer in the elderly is problematic. In many cases,
death from other causes may occur before death from prostate cancer. Choosing the optimal …

Dr. Middleton is Chairman of the Division of Urology at the University of Utah in Salt Lake
City, Utah, and Cochair of the Prostate Clinical Guidelines Panel of the American Urological …

Purpose: Controversy exists over the optimal treatment for patients with clinically localized
prostate cancer. Almost all of the treatment results are from non-randomized trials and …

PURPOSE: We investigated the long-term outcome of prostate cancer. MATERIALS AND
METHODS: Causes of death were examined in 490 patients diagnosed with prostate cancer …

Prostate cancer is now the most commonly diagnosed noncutaneous cancer in men.
Therefore, the decisions of which patients with prostate cancer require treatment and how to …

METHODS As of June 1971 there were 714 patients with carcinoma of the prostate recorded
in the tumor registry of the Mason Clinic. These patients were reviewed in 1972 and staged …

Objectives. To study the long-term survival of patients with prostate cancer, determine the
risk factors for prostate cancer death, and investigate the outcome of initially untreated …

The incidence and prevalence of prostate cancer is increasing. A number of aetiological
factors including age, race, family history and diet have been implicated. The majority of …